lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations
Endokrynologia Polska · 2025
DOI: 10.5603/ep.105397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, 2025. Verfasst von Xing Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Thyroid Cancer, Papillary, RNA, Long Noncoding, Thyroid Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. weibojun1015@126.com.
Zitieren
APA
Liu, X., Yang, W., Shen, R., Wang, J., Feng, D., Zhao, L., Shen, H., Zhao, T., Wang, Q., & Wei, B. (2025). lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations. Endokrynologia Polska. https://doi.org/10.5603/ep.105397
Vancouver
Liu X, Yang W, Shen R, Wang J, Feng D, Zhao L, et al. lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations. Endokrynologia Polska. 2025. doi:10.5603/ep.105397
BibTeX
@article{Liu2025,
author = {Liu, Xing and Yang, Wenjing and Shen, Rongfang and Wang, Jiacheng and Feng, Dalin and Zhao, Li and Shen, Hong and Zhao, Teng and Wang, Qian and Wei, Bojun},
title = {lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations},
journal = {Endokrynologia Polska},
year = {2025},
doi = {10.5603/ep.105397}
}
EUVIMED